Complications: *Blood clots* *Stroke* *Heart attack* *Organ damage* GLP-1 Receptor Agonists: A Promising Treatment for Polycythemia Vera Glucagon-Like Peptide-1 (GLP-1) receptor agonists have shown significant promise in treating polycythemia vera (PV), a rare blood disorder characterized by excessive production of red blood cells
Moreover, there are signals of increased incidence of cardiac arrhythmias associated with its use
When switching from a longer-acting medication (semaglutide) to a shorter-acting one (tirzepatide), or vice versa, the gastric emptying pattern shifts, potentially altering absorption of concurrent oral medications
[30] [28] Pharmacokinetics [edit] Endogenous GLP-1 has a plasma half-life of 1.52 minutes due to degradation by the ubiquitous enzymes, dipeptidyl peptidase-4 (DPP4) and neutral endopeptidases (NEP)
2024 Biopreventative Company Inc
E' possibile indicare nelle "note" una fascia oraria preferita, anche se questa non vincolante